Novel Approaches for HDL-Directed Therapies

Current Atherosclerosis Reports
J Genest, Hong Y Choi

Abstract

High-density lipoproteins (HDL) are thought to exert a protective role against atherosclerosis. The measurement of the cholesterol mass within HDL (HDL-C) represents a good biomarker of cardiovascular health, but HDL-C appears to be a poor therapeutic target. Here, we discuss new targets for the development of HDL-directed therapies. Among cardio-protective functions of HDL particles, the ability of HDL to remove cholesterol from cells involved in the early stages of atherosclerosis is considered one of the most important functions. This process, termed "HDL biogenesis," is initiated by the formation of highly specialized plasma membrane micro-domains by the ATP-binding cassette transporter A1 (ABCA1) and the binding of apolipoproteins (apo) such as apoA-I, the major protein moiety of HDL, to the micro-domains. Although early strategies aimed at increasing HDL biogenesis by upregulating ABCA1 or apoA-I gene expression have not met with clinical success, recent advances in understanding transcriptional, post-transcriptional, and post-translational regulatory pathways propose new targets for the promotion of HDL biogenesis. We have recently reported that a novel apoA-I-binding protein desmocollin 1 (DSC1) prevents HDL biogenesis ...Continue Reading

References

Aug 1, 1994·The Journal of Clinical Investigation·C PásztyE M Rubin
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·A VenkateswaranP Tontonoz
Feb 13, 2001·Biochemical and Biophysical Research Communications·A T RemaleyH B Brewer
Jan 16, 2002·The Journal of Biological Chemistry·Sean B JosephPeter Tontonoz
Jan 15, 2004·The Journal of Biological Chemistry·Youichi MunehiraKazumitsu Ueda
Jul 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Guoxun ChenMichael S Brown
May 15, 2010·Science·S Hani Najafi-ShoushtariAnders M Näär
May 15, 2010·Science·Katey J RaynerCarlos Fernández-Hernando
Jan 14, 2011·The New England Journal of Medicine·Amit V KheraDaniel J Rader
Apr 27, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tadahaya MizunoYuichi Sugiyama
Apr 18, 2012·Circulation·Robert S RosensonLaurent Yvan-Charvet
Apr 2, 2013·Journal of Lipid Research·Anatol KontushM John Chapman
May 28, 2013·DNA and Cell Biology·Yun-cheng LvChao-ke Tang
Jun 20, 2013·Cholesterol·Anouar Hafiane, Jacques Genest
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sarah PicaudPanagis Filippakopoulos
Jan 7, 2014·PloS One·Kevin G McLurePeter R Young
Jan 28, 2014·Nature Medicine·Ying HuangStanley L Hazen
Feb 7, 2014·The Journal of Biological Chemistry·Victar HsiehLeonard Kritharides
May 17, 2014·Nature Reviews. Drug Discovery·Cynthia Hong, Peter Tontonoz
May 24, 2014·Nature Reviews. Drug Discovery·Bronwyn A KingwellNorman E Miller
Jul 12, 2014·Nature Reviews. Drug Discovery·Zhonghan Li, Tariq M Rana
Jul 31, 2014·The Journal of Biological Chemistry·Michael C Phillips
Nov 19, 2014·The New England Journal of Medicine·Anand RohatgiPhilip W Shaul
Mar 31, 2015·Cell·Joseph L Goldstein, Michael S Brown
May 23, 2015·Journal of Lipid Research·Tomáš VaisarJay W Heinecke
Sep 15, 2015·The Journal of Clinical Investigation·Yanhong GuoY Eugene Chen
Dec 10, 2015·Journal of cardiology·Koh Ono
Mar 24, 2016·Cell Research·Xiaodong Huang, Vishva M Dixit

❮ Previous
Next ❯

Citations

Oct 13, 2021·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Ilaria ZanottiMarina Cuchel

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.